Polydimethylsiloxane (PDMS) is the predominant material used for organ-on-a-chip devices
and microphysiological systems (MPSs) due to its ease-of-use, elasticity, optical …

Synthetic biodegradable elastomers, such as polyesters and polyurethanes have
revolutionized biomedical therapeutic strategies and devices. Driven by innovations in …

Congenital and acquired valvular heart diseases (VHDs) are significant causes of mortality
worldwide. With valve replacement being the primary solution for VHD, current options …

The organ-on-a-chip (OoC) paves a way for biomedical applications ranging from preclinical
to clinical translational precision. The current trends in the in vitro modeling is to reduce the …

Biomaterials are considered a substantial building block for tissue engineering, regenerative
medicine, and drug delivery. Despite using both organic and inorganic biomaterials in these …

We developed a heart-on-a-chip platform that integrates highly flexible, vertical, 3D
micropillar electrodes for electrophysiological recording and elastic microwires for the …

Citrate‐based biodegradable polymers have emerged as a distinctive biomaterial platform
with tremendous potential for diverse medical applications. By harnessing their versatile …

Recent advances in both cardiac tissue engineering and hearts‐on‐a‐chip are grounded in
new biomaterial development as well as the employment of innovative fabrication …

Vascular diseases, such as atherosclerosis and thrombosis, are major causes of morbidity
and mortality worldwide. Traditional in vitro models for studying vascular diseases have …

Soft optomechanical systems have the ability to reversibly respond to optical and
mechanical external stimuli by changing their own properties (eg, shape, size, viscosity …